11-54603190-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001004703.1(OR4C46):c.809C>T(p.Ala270Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000882 in 1,587,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 7/11 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004703.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4C46 | NM_001004703.1 | c.809C>T | p.Ala270Val | missense_variant | 1/1 | ENST00000328188.1 | NP_001004703.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4C46 | ENST00000328188.1 | c.809C>T | p.Ala270Val | missense_variant | 1/1 | NM_001004703.1 | ENSP00000329056 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000725 AC: 11AN: 151756Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.00000799 AC: 2AN: 250430Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135362
GnomAD4 exome AF: 0.00000209 AC: 3AN: 1435868Hom.: 0 Cov.: 30 AF XY: 0.00000140 AC XY: 1AN XY: 716254
GnomAD4 genome AF: 0.0000724 AC: 11AN: 151874Hom.: 0 Cov.: 28 AF XY: 0.0000674 AC XY: 5AN XY: 74208
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 16, 2024 | The c.809C>T (p.A270V) alteration is located in exon 1 (coding exon 1) of the OR4C46 gene. This alteration results from a C to T substitution at nucleotide position 809, causing the alanine (A) at amino acid position 270 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at